XRAY is currently covered by 12 analysts with average potential upside of $8.16 (16.74%) backed by 108 price targets and 133 ratings. Documented since 08-Nov-2012. Analyst's average stock valuation to be materialised ratio is 58.09% with an average time for price targets to be met of 283.2 days.
Most recent stock forecast was given by NATHAN RICH from GOLDMAN on 02-Mar-2023.
Highest price target for XRAY is 67, Lowest price target is 28, average price target is 47.5.
Currently, out of the existing stock ratings of XRAY - 28 which are a Buy (65.12%), 15 which are a Hold (34.88%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
39
$1.25 (3.31%)
34
27 days ago
8/12 (66.67%)
$4.72 (10.83%)
180
Hold
35
$-2.75 (-7.28%)
38
1 months 23 days ago
8/13 (61.54%)
$7.85 (15.62%)
85
Buy
40
$2.25 (5.96%)
51
4 months 14 days ago
4/13 (30.77%)
$12.36 (25.13%)
434
Buy
39
$7.52 (23.89%)
42
4 months 14 days ago
1/12 (8.33%)
$11.35 (24.72%)
351
Hold
47
$9.25 (24.50%)
44
9 months 27 days ago
3/4 (75%)
$5.07 (12.17%)
37
What is XRAY(DENTSPLY SIRONA Inc) average time for price targets to be met?
Which analyst has the current highest performing score on XRAY(DENTSPLY SIRONA Inc) with a proven track record?
